- Home
- ZCMD vs GDTC Comparison
ZCMD vs GDTC Comparison
Compare ZCMD & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- GDTC
- Stock Information
- Founded
- ZCMD 2012
- GDTC 2018
- Country
- ZCMD China
- GDTC Singapore
- Employees
- ZCMD N/A
- GDTC N/A
- Industry
- ZCMD Other Consumer Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- GDTC Health Care
- Exchange
- ZCMD Nasdaq
- GDTC Nasdaq
- Market Cap
- ZCMD 28.5M
- GDTC 21.5M
- IPO Year
- ZCMD 2020
- GDTC 2023
- Fundamental
- Price
- ZCMD $1.03
- GDTC $1.89
- Analyst Decision
- ZCMD
- GDTC Buy
- Analyst Count
- ZCMD 0
- GDTC 1
- Target Price
- ZCMD N/A
- GDTC $5.00
- AVG Volume (30 Days)
- ZCMD 40.4K
- GDTC 18.1K
- Earning Date
- ZCMD 01-01-0001
- GDTC 01-01-0001
- Dividend Yield
- ZCMD N/A
- GDTC N/A
- EPS Growth
- ZCMD N/A
- GDTC N/A
- EPS
- ZCMD N/A
- GDTC N/A
- Revenue
- ZCMD $15,864,773.00
- GDTC $368,838.00
- Revenue This Year
- ZCMD N/A
- GDTC $5.37
- Revenue Next Year
- ZCMD N/A
- GDTC N/A
- P/E Ratio
- ZCMD N/A
- GDTC N/A
- Revenue Growth
- ZCMD N/A
- GDTC N/A
- 52 Week Low
- ZCMD $0.95
- GDTC $1.20
- 52 Week High
- ZCMD $2.97
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- ZCMD 41.90
- GDTC 37.08
- Support Level
- ZCMD $1.02
- GDTC $1.85
- Resistance Level
- ZCMD $1.08
- GDTC $1.95
- Average True Range (ATR)
- ZCMD 0.07
- GDTC 0.10
- MACD
- ZCMD -0.01
- GDTC -0.02
- Stochastic Oscillator
- ZCMD 8.70
- GDTC 28.00
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.